FLT4 and soft tissue sarcoma: Recent findings have somewhat questioned this traditional view, nevertheless, they have shown that VEGFD is also involved in vascular angiogenesis and, moreover, one of the VEGFD receptors, VEGFR3, has been found to be expressed on the very tumour cells in a fraction of soft tissue sarcomas, with a significant negative prognostic relevance [97].